STAT3 and breast cancer: We selected niclosamide based on available evidence of it potential to inhibit STAT3 phosphorylation and nuclear localization and systematically investigated its effects on adipocytes-induced EMT in MDA-MB-468 and MCF-7 breast cancer cells.